Skip to main content

Hemodynamic Formulas to remember

 

Hemodynamic formulas are fundamental tools in cardiology and critical care, allowing clinicians to quantify cardiac performance, vascular tone, and circulatory efficiency. Understanding these calculations helps in diagnosing shock states, guiding fluid therapy, titrating vasoactive drugs, and interpreting invasive hemodynamic monitoring.


Cardiac Output (CO) and Cardiac Index (CI):

Cardiac output represents the volume of blood pumped by the heart per minute and is calculated as stroke volume multiplied by heart rate (CO = SV × HR). Normal CO ranges from 4–8 L/min. Because CO varies with body size, cardiac index adjusts CO for body surface area (CI = CO/BSA), providing a more accurate assessment of cardiac performance. A normal CI is 2.2–4.0 L/min/m². Low CI suggests pump failure or hypovolemia, while high CI is seen in sepsis or hyperdynamic states.


Stroke Volume (SV) and Stroke Volume Index (SVI):

Stroke volume is the amount of blood ejected from the left ventricle with each heartbeat. It can be derived from CO using the formula SV = (CO × 1000) / HR, converting liters to milliliters. Normal SV is 60–100 mL/beat (approximately 1 mL/kg/beat). Stroke volume index further normalizes SV for body size (SVI = SV/BSA), with normal values of 33–47 mL/beat/m². Reduced SV or SVI indicates impaired preload, contractility, or increased afterload.


Mean Arterial Pressure (MAP):

MAP reflects the average arterial pressure throughout the cardiac cycle and is a key determinant of organ perfusion. It is calculated as MAP = DP + (SP − DP)/3. Normal MAP ranges from 70–100 mmHg. Clinically, a MAP ≥65 mmHg is generally required to maintain adequate organ perfusion, especially in critically ill patients.


Systemic Vascular Resistance (SVR):

SVR represents the resistance offered by the systemic circulation and is a measure of afterload. It is calculated using SVR = [(MAP − CVP) / CO] × 80. Normal SVR ranges from 800–1200 dyn·s/cm⁵. Elevated SVR is seen in vasoconstrictive states such as cardiogenic shock, while reduced SVR is characteristic of distributive shock, particularly sepsis.


Pulmonary Vascular Resistance (PVR):

PVR assesses resistance within the pulmonary circulation and is calculated as PVR = [(PAP − PCWP) / CO] × 80. Normal values are 50–250 dyn·s/cm⁵. Elevated PVR suggests pulmonary hypertension, pulmonary embolism, or hypoxic vasoconstriction and has important implications for right ventricular function.


Left Ventricular Stroke Work Index (LVSWI):

LVSWI quantifies the work performed by the left ventricle per beat, integrating preload, afterload, and contractility. It is calculated as LVSWI = SVI × (MAP − PCWP) × 0.0136. Normal values range from 45–75 g·m/m²/beat. Reduced LVSWI indicates impaired left ventricular performance, commonly seen in cardiogenic shock or advanced heart failure.


In summary, hemodynamic formulas provide a structured and quantitative approach to cardiovascular assessment. When interpreted together rather than in isolation, they offer deep insight into the underlying pathophysiology, helping clinicians tailor precise, physiology-guided management in both acute and chronic cardiovascular conditions.


Comments

Popular posts from this blog

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB)

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB) Why this differentiation matters Brugada pattern is a malignant channelopathy associated with sudden cardiac death, while incomplete RBBB is usually a benign conduction variant. Mislabeling Brugada as iRBBB can be fatal; overcalling iRBBB as Brugada can lead to unnecessary anxiety and ICD implantation. --- 1. Basic Definitions Brugada ECG Pattern Primary repolarization abnormality Genetic sodium-channel disorder Characteristic ST-segment elevation in V1–V3 Risk of ventricular fibrillation and sudden death Incomplete RBBB (iRBBB) Depolarization abnormality Delay in right ventricular conduction Common in healthy individuals Usually asymptomatic and benign --- 2. ECG Morphology: Side-by-Side Comparison QRS Duration Brugada: QRS usually <120 ms iRBBB: QRS <120 ms, but with RBBB morphology --- V1–V2 Pattern (Key Differentiator) Brugada Pseudo-RBBB appearance ST elevation ≥2 mm ST segment is coved or saddleback Terminal QRS bl...

π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š

 π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š in  Patient with AF and acute IS/TIA European Heart Association Guideline recommends: • 1 days after TIA • 3 days after mild stroke • 6 days after moderate stroke • 12 days after severe stroke Early anticoagulation can decrease a risk of recurrent stroke and embolic events but may increase a risk of secondary hemorrhagic transformation of brain infarcts.  The 1-3-6-12-day rule is a known consensus with graded increase in delay of anticoagulation between 1 and 12 days after onset of ischemic stroke or transient ischemic attack(TIA), according to neurological severity based on European expert opinions. However, this rule might be somewhat later than currently used in a real-world practical setting.

Acute Treatment of Hyperkalemia

Acute Treatment of Hyperkalemia – A Practical, Bedside-Oriented Guide Hyperkalemia is a potentially life-threatening electrolyte abnormality that demands prompt recognition and decisive management. The danger lies not only in the absolute potassium value but in its effects on cardiac conduction, which can rapidly progress to fatal arrhythmias. Acute treatment focuses on three parallel goals: stabilizing the cardiac membrane, shifting potassium into cells, and removing excess potassium from the body. Understanding this stepwise approach helps clinicians act quickly and rationally in emergency settings. Why Hyperkalemia Is Dangerous Potassium plays a key role in maintaining the resting membrane potential of cardiac myocytes. Elevated serum potassium reduces the transmembrane gradient, leading to slowed conduction, ECG changes, ventricular arrhythmias, and asystole. Importantly, ECG changes do not always correlate with potassium levels, so treatment decisions should be based on clinical c...